Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients.
Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment response.
Cold Spring Harbor Molecular Case Studies
Biswas, Romi R; Gao, Shaojian S; Cultraro, Constance M CM; Maity, Tapan K TK; Venugopalan, Abhilash A; Abdullaev, Zied Z; Shaytan, Alexey K AK; Carter, Corey A CA; Thomas, Anish A; Rajan, Arun A; Song, Young Y; Pitts, Stephanie S; Chen, Kevin K; Bass, Sara S; Boland, Joseph J; Hanada, Ken-Ichi KI; Chen, Jinqiu J; Meltzer, Paul S PS; Panchenko, Anna R AR; Yang, James C JC; Pack, Svetlana S; Giaccone, Giuseppe G; Schrump, David S DS; Khan, Javed J; Guha, Udayan U
Age-related mutations associated with clonal hematopoietic expansion and malignancies.
Nature Medicine
Xie, Mingchao M; Lu, Charles C; Wang, Jiayin J; McLellan, Michael D MD; Johnson, Kimberly J KJ; Wendl, Michael C MC; McMichael, Joshua F JF; Schmidt, Heather K HK; Yellapantula, Venkata V; Miller, Christopher A CA; Ozenberger, Bradley A BA; Welch, John S JS; Link, Daniel C DC; Walter, Matthew J MJ; Mardis, Elaine R ER; Dipersio, John F JF; Chen, Feng F; Wilson, Richard K RK; Ley, Timothy J TJ; Ding, Li L